Balance Sheet - Alto Neuroscience, Inc. (ANRO)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | |
|---|---|---|---|---|---|
| Total cash and short-term investments | 176.48 | 168.23 | 82.55 | 48.34 | 25.71 |
| Accounts receivable, net | 0.01 | 0.55 | 1.74 | ||
| Inventories | 0.00 | ||||
| Other current assets | 1.23 | 1.11 | 2.84 | 0.33 | 0.24 |
| Total current assets | 177.72 | 169.34 | 85.39 | 49.22 | 27.68 |
| Total non-current assets | 6.97 | 8.21 | 1.24 | 1.63 | 1.11 |
| Total assets | 184.69 | 177.54 | 86.63 | 50.85 | 28.79 |
| Total current liabilities | 11.33 | 10.01 | 5.61 | 5.56 | 1.81 |
| Total non-current liabilities | 22.22 | 16.07 | 152.69 | 83.70 | 39.46 |
| Total liabilities | 33.55 | 26.08 | 158.30 | 89.26 | 41.27 |
| Total stockholders' equity | 151.14 | 151.46 | -71.67 | -38.41 | -12.48 |
| Common shares outstanding | 29 | 25 | 27 | 26 | 26 |
Show Quarterly Balance Sheet
Balance Sheet - Alto Neuroscience, Inc. (ANRO)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 263.76 | 176.48 | 137.82 | 147.59 | 160.75 | 168.23 | 181.70 | 193.12 | 205.90 | 82.55 | 51.29 | 0.00 | 48.34 | 48.34 |
| Accounts receivable, net | 0.01 | 0.01 | 0.55 | |||||||||||
| Inventories | 0.64 | |||||||||||||
| Other current assets | 5.36 | 1.23 | 1.63 | 2.26 | 2.77 | 1.11 | 1.83 | 2.29 | 2.42 | 2.84 | 0.75 | 0.33 | ||
| Total current assets | 269.13 | 177.72 | 139.45 | 149.85 | 163.52 | 169.34 | 183.53 | 195.41 | 208.31 | 85.39 | 52.05 | 48.34 | 49.22 | |
| Total non-current assets | 7.13 | 6.97 | 7.56 | 8.03 | 8.39 | 8.21 | 8.08 | 1.95 | 1.61 | 1.24 | 1.19 | -48.34 | 1.63 | |
| Total assets | 276.26 | 184.69 | 147.01 | 157.88 | 171.92 | 177.54 | 191.61 | 197.36 | 209.92 | 86.63 | 53.24 | 50.85 | ||
| Total current liabilities | 13.12 | 11.33 | 9.05 | 8.13 | 7.26 | 10.01 | 14.02 | 9.84 | 8.01 | 5.61 | 5.98 | 5.56 | ||
| Total non-current liabilities | 19.78 | 22.22 | 26.40 | 26.34 | 25.56 | 16.07 | 12.54 | 7.74 | 8.81 | 152.69 | 108.35 | 83.70 | ||
| Total liabilities | 32.89 | 33.55 | 35.45 | 34.47 | 32.82 | 26.08 | 26.56 | 17.58 | 16.82 | 158.30 | 114.33 | 89.26 | ||
| Total stockholders' equity | 243.37 | 151.14 | 111.56 | 123.41 | 139.10 | 151.46 | 165.05 | 179.78 | 193.10 | -71.67 | -61.10 | 35.71 | -38.41 | |
| Common shares outstanding | 33 | 32 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 26 |